SCHEMBL17675152

SCHEMBL17675152

NC(=O)c1ncccc1S(=O)(=O)C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.38
TLR7 Q9NYK1 3/20 0.38
SLC40A1 Q9NP59 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
GAA P10253 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP3A4 P08684 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
BLM P54132 1/20 0.36
AGER Q15109 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CA2 P00918 2/20 0.36
CA1 P00915 1/20 0.36
MAPK1 P28482 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9301715 0.80 ACLY (0.50) TLR7SLC40A1L3MBTL1TDP1KDM4E
SCHEMBL8165111 0.80 CA1 (0.51) L3MBTL1MAPTKDM4EALDH1A1CYP3A4
SCHEMBL27804166 0.80 COMT (0.44) L3MBTL1MAPTKDM4EALDH1A1CYP3A4
SCHEMBL3914430 0.78 MKNK1 (0.41) SYKL3MBTL1MAPTKDM4EALDH1A1
SCHEMBL27726966 0.76 CA2 (0.40) SLC40A1GAATDP1ALDH1A1CA2
SCHEMBL18940878 0.75 COMT (0.49) L3MBTL1GAATDP1MAPTKDM4E
SCHEMBL25296983 0.74 MEN1 (0.48) L3MBTL1MAPTKDM4EALDH1A1CYP3A4
SCHEMBL18960863 0.74 MKNK1 (0.39) SLC40A1L3MBTL1GAAMAPTKDM4E
SCHEMBL29773169 0.74 TLR7 (0.46) TLR7
SCHEMBL28202739 0.74 TLR7 (0.46) TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3203840-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2017-08-16 EP disclosed
WO-2016057572-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MILLER MARK THOMAS (US) 2016-04-14 WO disclosed